Ferring Pharmaceuticals, Custom Ultrasonics & more — 5 GI company key notes

Here are five updates on GI companies from the past week.

Ferring Pharmaceuticals agreed to acquire Rebiotix for an unspecified sum.

The FDA approved Custom Ultrasonics' 83 Plus Automated Endoscope Reprocessors for use in healthcare facilities to wash and disinfect flexible endoscopes, duodenoscopes and scope accessories between uses.

Perrigo and Dexcel Pharma Technologies launched Omeprazole Delayed Release Orally Disintegrating Tablets, an over-the-counter medication to treat heartburn.

Chang-Hee Kim, PhD, of GoDx, won the 2018 AGA Shark Tank held at the 2018 AGA Tech Summit, March 21 to March 23 in Boston. Read more.

Becker's ASC Review profiled Boston Scientific.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast